MedTrace Logo

A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy

NCT03985371 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2022-01-05

No results posted yet for this study

Summary

The objective of this study is to collect preliminary efficacy and safety data on the use of EDTA EYE Drops (EED) on subjects during an episode of band keratopathy (BK).

Conditions

  • Corneal Dystrophy, Band-Shaped

Interventions

DRUG

EDTA Eye Drops

One drop in the Band Keratopathy affected eye only, two times per day for six months.

Sponsors & Collaborators

  • Livionex Inc.

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-29
Primary Completion
2021-09-30
Completion
2021-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03985371 on ClinicalTrials.gov